Education
About Us
Working with TipRanks
Follow Us
Biomerica Inc (BMRA)
NASDAQ:BMRA
BMRA Stock Chart & Stats
$2.46
-$0.02(-5.81%)
At close: 4:00 PM EST
$2.46
-$0.02(-5.81%)
Day’s Range― - ―
52-Week Range$2.08 - $10.16
Previous CloseN/A
Volume74.49K
Average Volume (3M)190.48K
Market Cap
$7.12M
Enterprise Value$5.58M
Total Cash (Recent Filing)$3.05M
Total Debt (Recent Filing)$373.00K
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Jan 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,869,900
10 Day Avg. Volume453,881
30 Day Avg. Volume190,481
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.71
Price to Sales (P/S)1.32
P/FCF Ratio-1.81
Enterprise Value/Market Cap0.78
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit8.77
Enterprise Value/Ebitda-1.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Biomerica News
BMRA FAQ
What was Biomerica Inc’s price range in the past 12 months?
Biomerica Inc lowest stock price was $2.08 and its highest was $10.16 in the past 12 months.
What is Biomerica Inc’s market cap?
Biomerica Inc’s market cap is $7.12M.
When is Biomerica Inc’s upcoming earnings report date?
Biomerica Inc’s upcoming earnings report date is Jan 21, 2026 which is in 73 days.
How were Biomerica Inc’s earnings last quarter?
Biomerica Inc released its earnings results on Oct 15, 2025. The company reported $0.001 earnings per share for the quarter, beating the consensus estimate of N/A by $0.001.
Is Biomerica Inc overvalued?
According to Wall Street analysts Biomerica Inc’s price is currently Overvalued.
Does Biomerica Inc pay dividends?
Biomerica Inc does not currently pay dividends.
What is Biomerica Inc’s EPS estimate?
Biomerica Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biomerica Inc have?
Biomerica Inc has 2,869,900 shares outstanding.
What happened to Biomerica Inc’s price movement after its last earnings report?
Biomerica Inc reported an EPS of $0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.694%.
Which hedge fund is a major shareholder of Biomerica Inc?
Currently, no hedge funds are holding shares in BMRA
Company Description
Biomerica Inc
Biomerica, Inc. (BMRA) is a biotechnology company focused on developing, manufacturing, and marketing innovative medical diagnostic products. The company specializes in the areas of gastrointestinal health, autoimmune diseases, and food intolerance, providing a range of diagnostic tests designed for point-of-care settings and home use. Its core products include a variety of tests for conditions such as celiac disease, inflammatory bowel disease, and other gastrointestinal disorders, as well as tests for food sensitivities and autoimmune disorders.
Technical Analysis
Strata Skin Sciences
―
PAVmed
―
Heart Test Laboratories, Inc.
―
Autonomix Medical, Inc.
―
Pheton Holdings Ltd. Class A
―
Ownership Overview
69.12% Insiders
7.49% Mutual Funds
0.05% Other Institutional Investors
22.84% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---